{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Chestnut Ridge",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "85333",
      "recalling_firm": "Par Pharmaceutical Inc.",
      "address_1": "1 Ram Ridge Rd",
      "address_2": "N/A",
      "postal_code": "10977-6714",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed within the United States.",
      "recall_number": "D-1071-2020",
      "product_description": "Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India   NDC# 49884-0065-01",
      "product_quantity": "29,352 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specification: Presence of unknown impurity observed.",
      "recall_initiation_date": "20200330",
      "center_classification_date": "20200330",
      "termination_date": "20211102",
      "report_date": "20200408",
      "code_info": "Lot # 32809101, Exp 3/2021"
    }
  ]
}